Effect of mutation order on myeloproliferative neoplasms.
暂无分享,去创建一个
Paola Guglielmelli | George S Vassiliou | Beatriz Bellosillo | Suraj Menon | Peter J Campbell | David C Wedge | David G Kent | Elli Papaemmanuil | Anthony R Green | Konstanze Döhner | P. Campbell | D. Kent | K. Döhner | D. Wedge | E. Papaemmanuil | S. Menon | A. Green | G. Vassiliou | P. Guglielmelli | A. Vannucchi | E. Baxter | A. Godfrey | C. Harrison | B. Bellosillo | J. Nangalia | C. Massie | Jyoti Nangalia | E Joanna Baxter | Charles E Massie | Alessandro Vannucchi | Claire N Harrison | Anna L Godfrey | C. Ortmann | Y. Silber | J. Grinfeld | D. Dimitropoulou | C. Besses | Jacob Grinfeld | Yvonne Silber | Christina A Ortmann | Danai Dimitropoulou | Carles Besses | Christina A. Ortmann | Anthony R. Green | David G. Kent | Charles E Massie | Claire N. Harrison | Peter J. Campbell | E. J. Baxter | Charlie E. Massie | Claire N Harrison
[1] Christian Beisel,et al. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. , 2014, Blood.
[2] O. Abdel-Wahab,et al. The role of mutations in epigenetic regulators in myeloid malignancies , 2012, Nature Reviews Cancer.
[3] W. Earnshaw,et al. The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis , 2012, Nature Reviews Molecular Cell Biology.
[4] G. Evan,et al. p53 — a Jack of all trades but master of none , 2009, Nature Reviews Cancer.
[5] L. Chin,et al. Non-germline genetically engineered mouse models for translational cancer research , 2010, Nature Reviews Cancer.
[6] E. Solary,et al. JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα. , 2013, Blood.
[7] W. Hahn,et al. Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.
[8] W. Vainchenker,et al. Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms. , 2009, Blood.
[9] Igor Jurisica,et al. Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment , 2011, Science.
[10] K. Rajewsky,et al. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice , 2011, Proceedings of the National Academy of Sciences.
[11] R. Levine,et al. Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.
[12] Xiaochun Yu,et al. TET2 promotes histone O-GlcNAcylation during gene transcription , 2012, Nature.
[13] M. Stratton,et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. , 2013, Blood.
[14] Peter J. Campbell,et al. Evolution of the cancer genome , 2012, Nature Reviews Genetics.
[15] B. Garvik,et al. Principles for the Buffering of Genetic Variation , 2001, Science.
[16] E. Dermitzakis,et al. Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling. , 2010, Cancer cell.
[17] Carlo C. Maley,et al. Clonal evolution in cancer , 2012, Nature.
[18] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[19] Peter W Zandstra,et al. Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. , 2012, Cell stem cell.
[20] David A. Williams,et al. Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera. , 2013, Blood.
[21] J. D. Fitzpatrick,et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. , 2013, The New England journal of medicine.
[22] Z. Chang,et al. Mitotic control of dTTP pool: a necessity or coincidence? , 2007, Journal of biomedical science.
[23] Yi Zhang,et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification , 2010, Nature.
[24] Peter A. Jones,et al. A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.
[25] K. Anderson,et al. Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.
[26] M. Murakami,et al. Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model. , 2013, Blood.
[27] K. Döhner,et al. TET genes: new players in DNA demethylation and important determinants for stemness. , 2011, Experimental hematology.
[28] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[29] J. Dick,et al. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development , 2010, Nature Immunology.
[30] D. Kent,et al. Self-Renewal of Single Mouse Hematopoietic Stem Cells Is Reduced by JAK2V617F Without Compromising Progenitor Cell Expansion , 2013, PLoS biology.
[31] Anindya Dutta,et al. Genomic instability in cancer. , 2013, Cold Spring Harbor perspectives in biology.
[32] Mithat Gonen,et al. Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.
[33] J. Pines,et al. APC/CCdh1 Targets Aurora Kinase to Control Reorganization of the Mitotic Spindle at Anaphase , 2008, Current Biology.
[34] B. Garvik,et al. Principles for the buffering of genetic variation. , 2001 .
[35] O. Abdel-Wahab,et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.
[36] A. Ashworth,et al. Genetic Interactions in Cancer Progression and Treatment , 2011, Cell.
[37] Jason Gotlib,et al. A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. , 2012, The New England journal of medicine.
[38] P. Campbell,et al. JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia. , 2010, Blood.
[39] J M Piret,et al. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin , 1996, The Journal of experimental medicine.